Interfered with RTKN2 expression could inhibit the migration and invasion of NSCLC cells by upregulating the expression of matrix metalloproteinase 9 (MMP9) and matrix metalloproteinase 2 (MMP2) (43). Here, RTKN2 is linked to non-small cell lung carcinoma.